Aishima M, Tomoda T, Yunoki T, Nakano T, Seki N, Yonemitsu Y, Sueishi K, Naito S, Ito Y, Teramoto N
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Br J Pharmacol. 2006 Nov;149(5):542-50. doi: 10.1038/sj.bjp.0706893. Epub 2006 Oct 3.
ATP-sensitive K+ channels (K(ATP) channels) play important roles in regulating the resting membrane potential of detrusor smooth muscle. Actions of ZD0947, a novel KATP channel opener, on both carbachol (CCh)-induced detrusor contractions and membrane currents in human urinary bladder myocytes were investigated.
Tension measurements and patch-clamp techniques were utilized to study the effects of ZD0947 in segments of human urinary bladder. Immunohistochemistry was also performed to detect the expression of the sulphonylurea receptor 1 (SUR1) and the SUR2B antigens in human detrusor muscle.
ZD0947 (> or = 0.1 microM) caused a concentration-dependent relaxation of the CCh-induced contraction of human detrusor, which was reversed by glibenclamide. The rank order of the potency to relax the CCh-induced contraction was pinacidil > ZD0947 > diazoxide. In conventional whole-cell configuration, ZD0947 (> or = 1 microM) caused a concentration-dependent inward K+ current which was suppressed by glibenclamide at -60 mV. When 1 mM ATP was included in the pipette solution, application of pinacidil or ZD0947 caused no inward K+ current at -60 mV. Gliclazide (< or =1 microM), a selective SUR1 blocker, inhibited the ZD0947-induced currents (Ki = 4.0 microM) and the diazoxide-induced currents (high-affinity site, Ki1 = 42.4 nM; low-affinity site, Ki2 = 84.5 microM) at -60 mV. Immunohistochemical studies indicated the presence of SUR1 and SUR2B proteins, which are constituents of KATP channels, in the bundles of human detrusor smooth muscle.
These results suggest that ZD0947 caused a glibenclamide-sensitive detrusor relaxation through activation of glibenclamide-sensitive KATP channels in human urinary bladder.
ATP敏感性钾通道(K(ATP)通道)在调节逼尿肌平滑肌静息膜电位方面发挥重要作用。研究了新型KATP通道开放剂ZD0947对卡巴胆碱(CCh)诱导的逼尿肌收缩以及人膀胱肌细胞膜电流的作用。
采用张力测量和膜片钳技术研究ZD0947对人膀胱组织条的影响。还进行了免疫组织化学检测人逼尿肌中磺脲类受体1(SUR1)和SUR2B抗原的表达。
ZD0947(≥0.1微摩尔/升)引起CCh诱导的人逼尿肌收缩呈浓度依赖性松弛,该作用被格列本脲逆转。松弛CCh诱导收缩的效力顺序为吡那地尔>ZD0947>二氮嗪。在传统全细胞模式下,ZD0947(≥1微摩尔/升)引起浓度依赖性内向钾电流,在-60毫伏时被格列本脲抑制。当移液管溶液中含有1毫摩尔/升ATP时,施加吡那地尔或ZD0947在-60毫伏时未引起内向钾电流。格列齐特(≤1微摩尔/升),一种选择性SUR1阻滞剂,在-60毫伏时抑制ZD0947诱导的电流(抑制常数Ki = 4.0微摩尔/升)和二氮嗪诱导的电流(高亲和力位点,抑制常数Ki1 = 42.4纳摩尔/升;低亲和力位点,抑制常数Ki2 = 84.5微摩尔/升)。免疫组织化学研究表明,人逼尿肌平滑肌束中存在KATP通道的组成成分SUR1和SUR2B蛋白。
这些结果表明,ZD0947通过激活人膀胱中对格列本脲敏感的KATP通道引起对格列本脲敏感的逼尿肌松弛。